Reagent safety issues surface for cell/tissue therapies

Article Abstract:

The standard-setting organization US Pharmacopeia (USP) plans to publish a document that will give advice to companies regarding the measures that are to be taken for demonstrating the safety of the ancillary reagents that are use in the preparation of cell, gene and tissue therapies. The document of the USP will provide recommendations regarding the use of the ancillary reagents in clinical work; address the lack of specific guidance from the US Food and Drug Administration (FDA).

Pharmaceutical preparations, Services information, Pharmaceutical industry, Services, Powers and duties, United States. Food and Drug Administration, Pharmacopeia Inc.

---

Biotech awaits single European financial market

Article Abstract:

Financial Services Action Plan (FSAP) is designed to establish similar regulations for current markets and aims at creating a single financial market for Europe by 2005. International Accounting Standard will help investors to carry out comparisons not only between European and US shares but also across Europe.

Evaluation, Surveys, Financial markets, Biotechnologists, United Kingdom. Financial Services Authority

---

Network aims to knit disparate European initiatives

Article Abstract:

Eurobiocluster South a European biotech networks attempted to exploit synergies, pool expertise and avoid duplication of research efforts at the national level. The aim of the initiative is to foster competitive biotech collaborations in the public and private sector across national boundaries.

General services, Drugs, Biotechnology industry, Biotechnology industries, Company systems management, Information management, Enterprise networks, Pharmaceutical biotechnology, Enterprise network

Similar abstracts:

• Abstracts: boosting productivity is key in hard PR times. The road to prosperity during uncertain times. Shoot for 25% profit in '07
• Abstracts: It's not just about saving a few bucks anymore. Optimizing the financial supply chain to generate cash flow and reduce financial costs
• Abstracts: Beyond psychophysics: the need for a cognitive engineering approach to setting limits in manual lifting tasks
• Abstracts: Genentech raises stakes on PARP inhibitors. European pharma consolidation generates quality spinoffs. EMEA struggles with need to restructure
• Abstracts: Scripps lured to Sunshine State. Companies jostle for access to public markets. Increasing number of companies found ineligible for SBIR funding

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.